Trial · NCT03338569
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With ICU Mortality | 28 days | Outcome is reported as the number of patients who expired while receiving care in the intensive care unit (ICU). |
| Primary | All Cause Mortality at 28 Days | 28 days | Outcome is reported as the number of participants who have expired at 28 days post intervention |
| Secondary | Duration of Vasopressor Therapy | 28 days | Outcome is reported as the duration in hours of vasopressor therapy post intervention administration |
| Secondary | Duration of ICU Stay Post Intervention Administration | 28 days | Outcome is reported as the duration (in days) that participants require care in the intensive care unit (ICU) post intervention administration |
| Secondary | Time to Lactate Clearance Post Intervention Administration | 28 days | |
| Secondary | Rate of Lactate Clearance Post Intervention Administration | 24, 48, 72, and 96 hours post intervention | Outcome is reported as the number of participants who clear lactate from the bloodstream at 24, 48, 72, and 96 hours post intervention. Clearance is defined as a serum concentration of 2.0 mmol/l or less. |
| Secondary | Rate of Procalcitonin Clearance Post Intervention Administration | 4 days | |
| Secondary | Number of Participants With Need for Renal Replacement Therapy | 4 days | Outcome is reported as the number of participants who require renal replacement therapy |
| Secondary | Change in Serum Creatinine | Baseline and 4 days | Outcome is report as the change in serum creatinine between baseline and 4 days following treatment. Outcome is reported in units of mg/dl. |
| Secondary | Change in Sequential Organ Failure Assessment (SOFA) Score | Baseline and 4 days | SOFA score is a mortality prediction score that is based on the degree of dysfunction of 6 organ systems. Total scores range from 0 to 24, with higher scores indicating higher likely mortality. |
| Secondary | Change in Acute Physiology and Chronic Health Evaluation (APACHE) Scores | Baseline and 4 days | APACHE score is a severity-of-disease classification system that is calculated from a patient's age and 12 routine physiological measurements. Total scores are computed based on several measurements and range from 0 to 71 with higher scores corresponding to more severe disease and a higher risk of death. |
| Secondary | Total Intravenous Fluid Administered | 24 hours | Outcome is reported as the total volume of intravenous fluid (in liters) administered to participants during 24 hours following the initiation of study treatment. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03338569/registered